weight loss forecasts

Medifast To Launch National Marketing Campaign

May 20, 2024 Medifast today announced the launch of the first phase of its multimillion-dollar national marketing campaign. The campaign will highlight OPTAVIA’s new offering in collaboration with LifeMD®, the GLP-1 Lifestyle Program. View the full release here: https://www.businesswire.com/news/home/20240520770526/en/ This will be an investment of up to $30 million in company-led marketing efforts. Medifast is committed […]

Medifast To Launch National Marketing Campaign Read More »

Telehealth Weight Loss Market Worth $6.9 Billion And Growing

News / John LaRosa

April 13, 2024 Marketdata LLC (parent company of DietBusinessWatch) has just released new research, a report entitled: “The Telehealth Weight Loss Market”. The market for weight loss programs delivered via telehealth / telemedicine companies is worth $6.9 billion, and growing. Telehealth soared during the pandemic in 2020 as consumers stayed home and communicated with their

Telehealth Weight Loss Market Worth $6.9 Billion And Growing Read More »

Weight Watchers Reports Q4 and 2023 Results

News / John LaRosa

Feb. 28, 2024 WW reported its results for Q4 2023 and the full year today. WW reported results in line with analysts’ expectations in Q4 FY2023, with revenue down 8% year on year to $206 million. “2023 was a pivotal year as we began transforming our business for the future. We returned WeightWatchers to year

Weight Watchers Reports Q4 and 2023 Results Read More »

Bariatric Surgery Volume Sees Big Increase In 2021

News / John LaRosa

January 30, 2024 Based on the latest data from the ASMBS (American Society for Metabolic and Bariatric Surgery), the number of surgeries performed jumped by 32% in 2021, to 262,893. This happened during the pandemic, which is surprising, since many elective procedures were postponed. This was about 25% higher than Marketdata’s estimate in our March

Bariatric Surgery Volume Sees Big Increase In 2021 Read More »

Weight Watchers Reports 3rd Quarter Results

News / John LaRosa

November 2, 2023 WW reported results for its 3rd quarter. Management reported that: “We have successfully returned WeightWatchers to subscriber growth, with Q3 end of period subscribers up 6% year-over-year to 4.0 million. This is a significant achievement and a direct result of our work in reinvigorating our core product,” said Sima Sistani, the company’s

Weight Watchers Reports 3rd Quarter Results Read More »

Weight Loss Market Recovers to $75 Billion – New Marketdata Report

News, Uncategorized / John LaRosa

March 20, 2023 Marketdata LLC, Tampa, FL, has just released it 17th Edition of its best-selling market research report: “The U.S. Weight Loss & Diet Control Market”. At 427 pages, with 160 Tables & Charts and 34 in-depth diet company competitor profiles, this is the most comprehensive analysis anywhere of the market. Some findings… The

Weight Loss Market Recovers to $75 Billion – New Marketdata Report Read More »

Weight Loss Market Rebounds in 2021 From 25% Decline in 2020 – New Report

News, Uncategorized / John LaRosa

March 5, 2022 Marketdata’s new report, The U.S. Weight Loss Market: 2022 Status Report & Forecast (March 2022, 90 pp.) has just been released. Major Findings: The value of the U.S. weight loss market is estimated to have declined by a historic 25% in 2020, to $58 billion. as a result of closures of weight loss centers and

Weight Loss Market Rebounds in 2021 From 25% Decline in 2020 – New Report Read More »

Trouble at Noom?

News, Uncategorized / John LaRosa

Feb. 3, 2022 As reported here and in many other publications, Noom’s rapid growth as a weight loss program is well known. The company may plan an IPO this year, and it’s estimated that revenues topped $600 million last year. The company has raised $669 million to date. However, there may be some weak spots.

Trouble at Noom? Read More »

Semaglutide a Game Changer Drug?

News, Uncategorized / John LaRosa

Dec. 30, 2021 2021 was a historic year for obesity treatment. In June, the Food and Drug Administration approved the weight loss drug semaglutide, which some experts described as a “game changer”. The medication, initially developed to treat Type 2 diabetes, was the first drug treatment to be approved by the FDA for weight management since 2014. Wegovy,

Semaglutide a Game Changer Drug? Read More »

WW’s CEO Mindy Grossman To Step Down

News, Uncategorized / John LaRosa

Oct. 2, 2021 WW International, Inc. (WW) announced that Mindy Grossman, President and CEO, who has led the brand’s transformation since 2017, has decided to step down as President and CEO after the first quarter of 2022. Ms. Grossman will continue to lead the company until that time and will work with the Board of Directors

WW’s CEO Mindy Grossman To Step Down Read More »

(813) 971-8080